Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

Single and multiple factors analysis of the therapeutic effect in 131I treatment of Graves’ disease in elderly

Li Xiaomin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1473;
Li Xiaomin
1Nuclear Medicine, Shanxi Academy of Medical Sciences, Shanxi Dayi Hospital, Taiyuan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1473

Objectives To study the factors influencing therapeutic effect of 131I in treating Graves disease in elderly.

Methods All the 278 patients over 60 years old with Graves’hyperthyroidism who received 131I therapy between 2006 and 2011 were intensively followed up, among which, 220(mean age 65.35±5.00 years,including 50 males and 150 females)were successfully followed up. Curative effects of all patients were judged only in a single visit.Each patient was evaluated once for therapeutic efficacy. The assessment of the therapeutic effect was made according to cure (including hypothyroidism)and not-cured(including improvement and ineffectiveness) after 131I therapy. According to the calculation formula of 131I dose and clinical experience, the factors that may affect efficacy of 131I therapy were determined, including age, sex, thyroid weight, disease duration, severity of disease, course of ATD treatment,total dose of 131I, 24h RAIU. 220 patients were divided into 5 groups according to the follow-up time, Chi-square test was used to analyze the curative effect with 131I therapy of the 5 groups. Stepwise logistic regression was used to analyze the influencing factors of efficacy with 131I therapy.

Results 1. After more than 1 years ,72.7% of the cases were cured, 25.4%were improved, and 1.8% were unchanged. 2. The results of multivariate analysis showed that the age of patients, the weight of thyroid, 24h-RAIU, and the giving 131I dosage/g thyroid tissue were correlated to not-cured. The logistic regression equation was statistically significant.

Conclusions 1. Radioactive 131I is a very effective treatment method for Graves' disease in elderly patient. 2. In older patients and those patients whose thyroid weight is bigger than 60g, 24h-RAIU is higher, the given 131I dose per gram tissue of thyroid should be increased,in order to increase the curative ratio.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Single and multiple factors analysis of the therapeutic effect in 131I treatment of Graves’ disease in elderly
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Single and multiple factors analysis of the therapeutic effect in 131I treatment of Graves’ disease in elderly
Li Xiaomin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1473;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Single and multiple factors analysis of the therapeutic effect in 131I treatment of Graves’ disease in elderly
Li Xiaomin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 1473;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Clinical Significance of Circulating Anti-Thyroglobulin Autoantibodies After First Remnant Ablation in Patients with Differentiated Thyroid Cancer
  • Feasibility demonstration of imaging in vivo biodistribution of Yttrium-90 microspheres after radioembolization with a digital detector PET/CT system.
  • Postoperative-stimulated serum thyroglobulin levels measured just before the initial I-131ablation is useful for prediction of disease status in patients with low-risk differentiated thyroid cancer
Show more Oncology: Basic, Translational & Therapy

MTA I: Radiopharmaceutical Therapy Posters

  • Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus
  • Monitoring radioiodine-induced apoptotic and autophagic cell death in mouse colon cancer model
  • Ac-225-PSMA617 - a single center experience of 40 patients receiving PSMA-targeted Alpha therapy
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire